Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 551

1.

The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis.

Kimball AB, Sundaram M, Gauthier G, Guérin A, Pivneva I, Singh R, Ganguli A.

Dermatol Ther (Heidelb). 2018 Oct 10. doi: 10.1007/s13555-018-0264-z. [Epub ahead of print]

PMID:
30306395
2.

Whole body heat exposure modulates acute glucose metabolism.

Kimball AL, McCue PM, Petrie MA, Shields RK.

Int J Hyperthermia. 2018 Oct 10:1-8. doi: 10.1080/02656736.2018.1516303. [Epub ahead of print]

PMID:
30303421
3.

Overview and update on biologic therapy for moderate-to-severe hidradenitis suppurativa.

Porter ML, Golbari NM, Lockwood SJ, Kimball AB.

Semin Cutan Med Surg. 2018 Sep;37(3):182-189. doi: 10.12788/j.sder.2018.041.

PMID:
30215636
4.

Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: An integrated analysis from 11 clinical trials.

Langley RG, Kimball AB, Nakagawa H, Xu W, Pangallo B, Osuntokun OO, Agada N, Reich K.

J Eur Acad Dermatol Venereol. 2018 Sep 10. doi: 10.1111/jdv.15242. [Epub ahead of print]

PMID:
30198588
5.

Predictions, Surprises, and the Future of the Dermatology Workforce.

Porter ML, Kimball AB.

JAMA Dermatol. 2018 Sep 5. doi: 10.1001/jamadermatol.2018.2925. [Epub ahead of print] No abstract available.

PMID:
30193360
6.

Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.

Zouboulis CC, Bechara FG, Dickinson-Blok JL, Gulliver W, Horváth B, Hughes R, Kimball AB, Kirby B, Martorell A, Podda M, Prens EP, Ring HC, Tzellos T, van der Zee HH, van Straalen KR, Vossen ARJV, Jemec GBE.

J Eur Acad Dermatol Venereol. 2018 Sep 3. doi: 10.1111/jdv.15233. [Epub ahead of print] Review.

PMID:
30176066
7.

TEMPORARY REMOVAL: Online communications amongst hidradenitis suppurativa patients on Facebook.

Golbari NM, Porter ML, Kimball AB.

J Am Acad Dermatol. 2018 Aug 28. pii: S0190-9622(18)32485-X. doi: 10.1016/j.jaad.2018.08.031. [Epub ahead of print]

PMID:
30165167
8.

Discordance Between Patient Reported Motivations to Seek Treatment for Psoriasis Compared to Television Advertisements.

Golbari NM, Porter ML, Kimball AB.

J Drugs Dermatol. 2018 Aug 1;17(8):886-887.

PMID:
30124728
9.

Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years.

Griffiths CEM, Papp KA, Kimball AB, Randazzo B, Song M, Li S, Shen YK, Blauvelt A.

J Drugs Dermatol. 2018 Aug 1;17(8):826-832.

PMID:
30124721
10.

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma.

Yazbeck V, Shafer D, Perkins EB, Coppola D, Sokol L, Richards KL, Shea T, Ruan J, Parekh S, Strair R, Flowers C, Morgan D, Kmieciak M, Bose P, Kimball A, Badros AZ, Baz R, Lin HY, Zhao X, Reich RR, Tombes MB, Shrader E, Sankala H, Roberts JD, Sullivan D, Grant S, Holkova B.

Clin Lymphoma Myeloma Leuk. 2018 Sep;18(9):569-575.e1. doi: 10.1016/j.clml.2018.05.023. Epub 2018 Jun 6.

PMID:
30122201
11.

Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II.

Kimball AB, Tzellos T, Calimlim BM, Teixeira HD, Geng Z, Okun MM.

Acta Derm Venereol. 2018 Nov 5;98(10):932-937. doi: 10.2340/00015555-3012.

12.

Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa.

Golbari NM, Porter ML, Kimball AB.

J Am Acad Dermatol. 2018 Jul 9. pii: S0190-9622(18)32222-9. doi: 10.1016/j.jaad.2018.06.063. [Epub ahead of print]

PMID:
30003993
13.

Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.

Kimball AB, Ganguli A, Fleischer A.

J Eur Acad Dermatol Venereol. 2018 Jun 29. doi: 10.1111/jdv.15163. [Epub ahead of print]

PMID:
29959796
14.

Murine macrophage chemokine receptor CCR2 plays a crucial role in macrophage recruitment and regulated inflammation in wound healing.

Boniakowski AE, Kimball AS, Joshi A, Schaller M, Davis FM, denDekker A, Obi AT, Moore BB, Kunkel SL, Gallagher KA.

Eur J Immunol. 2018 Sep;48(9):1445-1455. doi: 10.1002/eji.201747400. Epub 2018 Jun 26.

PMID:
29879295
15.

Heliox Adjunct Therapy for Neonates With Congenital Diaphragmatic Hernia.

Wise AC, Boutin MA, Knodel EM, Proudfoot JA, Lane BP, Evans ML, Suttner DM, Kimball AL.

Respir Care. 2018 Sep;63(9):1147-1153. doi: 10.4187/respcare.06079. Epub 2018 May 22.

PMID:
29789411
16.

Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials.

Kimball AB, Sundaram M, Shields AL, Hudgens S, Okun M, Foley C, Ganguli A.

J Am Acad Dermatol. 2018 Dec;79(6):1141-1143. doi: 10.1016/j.jaad.2018.05.015. Epub 2018 May 19. No abstract available.

PMID:
29787843
17.

Assessment of treatment-seeking behaviour in patients with psoriasis.

Golbari NM, Lockwood SJ, Porter ML, Kimball AB.

Br J Dermatol. 2018 Oct;179(4):989-990. doi: 10.1111/bjd.16778. Epub 2018 Aug 6. No abstract available.

PMID:
29758088
18.

Clinical outcomes after varicose vein procedures in octogenarians within the Vascular Quality Initiative Varicose Vein Registry.

Sutzko DC, Obi AT, Kimball AS, Smith ME, Wakefield TW, Osborne NH.

J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):464-470. doi: 10.1016/j.jvsv.2018.02.008. Epub 2018 May 8.

PMID:
29752187
19.

Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Kimball AB, Augustin M, Gordon KB, Krueger GG, Pariser D, Fakharzadeh S, Goyal K, Calabro S, Lee S, Lin R, Li N, Srivastava B, Guenther L.

Br J Dermatol. 2018 Oct;179(4):984-986. doi: 10.1111/bjd.16737. Epub 2018 Jul 20. No abstract available.

PMID:
29747219
20.

Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials.

Blauvelt A, Reich K, Papp KA, Kimball AB, Gooderham M, Tyring SK, Sinclair R, Thaçi D, Li Q, Cichanowitz N, Green S, La Rosa C.

Br J Dermatol. 2018 Sep;179(3):615-622. doi: 10.1111/bjd.16724. Epub 2018 Jul 4.

PMID:
29742274
21.

Current guidelines for psoriasis treatment: a work in progress.

Golbari NM, Porter ML, Kimball AB.

Cutis. 2018 Mar;101(3S):10-12. Review.

PMID:
29718028
22.

Response to: Remission of hidradenitis suppurativa after bariatric surgery.

Golbari NM, Lee Porter M, Kimball AB.

JAAD Case Rep. 2018 Mar 9;4(3):278-279. doi: 10.1016/j.jdcr.2017.11.024. eCollection 2018 Apr. No abstract available.

23.

Efficacy and safety of ixekizumab over 4 years of open-label treatment in a phase 2 study in chronic plaque psoriasis.

Zachariae C, Gordon K, Kimball AB, Lebwohl M, Blauvelt A, Leonardi C, Braun D, McKean-Matthews M, Burge R, Cameron G.

J Am Acad Dermatol. 2018 Aug;79(2):294-301.e6. doi: 10.1016/j.jaad.2018.03.047. Epub 2018 Apr 10.

PMID:
29653208
24.

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.

Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Kimball AB, Cush JJ, Cooney M, Shaughnessy L, Vanderkelen M, Förger F.

Arthritis Rheumatol. 2018 Sep;70(9):1399-1407. doi: 10.1002/art.40508. Epub 2018 Jul 22.

25.

Late characterisation of cardiac effects following anthracycline and trastuzumab treatment in breast cancer patients.

Kimball A, Patil S, Koczwara B, Raman KS, Perry R, Grover S, Selvanayagam J.

Int J Cardiol. 2018 Jun 15;261:159-161. doi: 10.1016/j.ijcard.2018.03.025. Epub 2018 Mar 8.

PMID:
29576422
26.

Patient-reported symptoms and signs of moderate-to-severe psoriasis treated with guselkumab or adalimumab: results from the randomized VOYAGE 1 trial.

Papp KA, Blauvelt A, Kimball AB, Han C, Randazzo B, Wasfi Y, Shen YK, Li S, Griffiths CEM.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1515-1522. doi: 10.1111/jdv.14910. Epub 2018 Apr 10.

27.

Ly6CHi Blood Monocyte/Macrophage Drive Chronic Inflammation and Impair Wound Healing in Diabetes Mellitus.

Kimball A, Schaller M, Joshi A, Davis FM, denDekker A, Boniakowski A, Bermick J, Obi A, Moore B, Henke PK, Kunkel SL, Gallagher KA.

Arterioscler Thromb Vasc Biol. 2018 May;38(5):1102-1114. doi: 10.1161/ATVBAHA.118.310703. Epub 2018 Mar 1.

PMID:
29496661
28.

Increased Prevalence of Cancer in Adult Patients With Psoriasis in the United States: A Claims Based Analysis.

Kimball AB, Sundaram M, Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Guérin A, Ganguli A.

J Drugs Dermatol. 2018 Feb 1;17(2):180-186.

PMID:
29462226
29.

Host-associated bacterial community succession during amphibian development.

Prest TL, Kimball AK, Kueneman JG, McKenzie VJ.

Mol Ecol. 2018 Apr;27(8):1992-2006. doi: 10.1111/mec.14507. Epub 2018 Mar 23.

PMID:
29411448
30.

Dysfunctional Wound Healing in Diabetic Foot Ulcers: New Crossroads.

Davis FM, Kimball A, Boniakowski A, Gallagher K.

Curr Diab Rep. 2018 Jan 23;18(1):2. doi: 10.1007/s11892-018-0970-z. Review.

PMID:
29362914
31.

Carfilzomib for relapsed or refractory multiple myeloma - Authors' reply.

Dimopoulos MA, Kimball AS.

Lancet Oncol. 2018 Jan;19(1):e2. doi: 10.1016/S1470-2045(17)30920-8. No abstract available.

PMID:
29304357
32.

Understanding patient engagement in psoriasis treatment.

Golbari NM, Lockwood SJ, Porter ML, Kimball AB.

Br J Dermatol. 2018 Apr;178(4):988-989. doi: 10.1111/bjd.16266. Epub 2018 Mar 6. No abstract available.

PMID:
29274082
33.

A Beginner's Guide to Analyzing and Visualizing Mass Cytometry Data.

Kimball AK, Oko LM, Bullock BL, Nemenoff RA, van Dyk LF, Clambey ET.

J Immunol. 2018 Jan 1;200(1):3-22. doi: 10.4049/jimmunol.1701494.

PMID:
29255085
34.

Age-induced and photoinduced changes in gene expression profiles in facial skin of Caucasian females across 6 decades of age.

Kimball AB, Alora-Palli MB, Tamura M, Mullins LA, Soh C, Binder RL, Houston NA, Conley ED, Tung JY, Annunziata NE, Bascom CC, Isfort RJ, Jarrold BB, Kainkaryam R, Rocchetta HL, Swift DD, Tiesman JP, Toyama K, Xu J, Yan X, Osborne R.

J Am Acad Dermatol. 2018 Jan;78(1):29-39.e7. doi: 10.1016/j.jaad.2017.09.012. Epub 2017 Nov 14.

PMID:
29146147
35.

Adverse Reactions to Biologics in Psoriasis.

Lockwood SJ, Prens LM, Kimball AB.

Curr Probl Dermatol. 2018;53:1-14. doi: 10.1159/000478072. Epub 2017 Nov 7.

PMID:
29131033
36.

Amplified hearing device use in acute care settings for patients with hearing loss: A feasibility study.

Kimball AR, Roscigno CI, Jenerette CM, Hughart KM, Jenkins WW, Hsu W.

Geriatr Nurs. 2018 May - Jun;39(3):279-284. doi: 10.1016/j.gerinurse.2017.10.009. Epub 2017 Nov 10.

PMID:
29129447
37.

Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Strober B, Gooderham M, de Jong EMGJ, Kimball AB, Langley RG, Lakdawala N, Goyal K, Lawson F, Langholff W, Hopkins L, Fakharzadeh S, Srivastava B, Menter A.

J Am Acad Dermatol. 2018 Jan;78(1):70-80. doi: 10.1016/j.jaad.2017.08.051. Epub 2017 Nov 6.

38.

Telehealth Systems.

Mechanic OJ, Kimball AB.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 May 13.

39.

Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension.

Kimball AB, Luger T, Gottlieb A, Puig L, Kaufmann R, Burge R, Lin CY, Yosipovitch G.

Acta Derm Venereol. 2018 Jan 12;98(1):98-102. doi: 10.2340/00015555-2801.

40.

Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA).

Mehdizadeh A, Alavi A, Alhusayen R, Bauer B, Bechara FG, Bourcier M, Brassard A, Djamei V, Dutz J, George R, Ghias M, Gooderham M, Hamzavi I, Hoffman LK, Hou A, Hu H, Kimball AB, Kirchhof M, Kryzskaya D, Liy Wong MDC, Lowes MA, Lynde CW, McLellen C, Prens E, Prens L, Rogalska T, Sibbald RG, Sisic M, Tan MG, Wong DD.

Exp Dermatol. 2018 Jan;27(1):104-112. doi: 10.1111/exd.13445. Epub 2017 Nov 15.

PMID:
28898476
41.

Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial.

Dimopoulos MA, Goldschmidt H, Niesvizky R, Joshua D, Chng WJ, Oriol A, Orlowski RZ, Ludwig H, Facon T, Hajek R, Weisel K, Hungria V, Minuk L, Feng S, Zahlten-Kumeli A, Kimball AS, Moreau P.

Lancet Oncol. 2017 Oct;18(10):1327-1337. doi: 10.1016/S1470-2045(17)30578-8. Epub 2017 Aug 23. Erratum in: Lancet Oncol. 2017 Oct;18(10):e562.

PMID:
28843768
42.

Cover Image, Volume 173A, Number 9, September 2017.

Kruszka P, Porras AR, Addissie YA, Moresco A, Medrano S, Mok GTK, Leung GKC, Tekendo-Ngongang C, Uwineza A, Thong MK, Muthukumarasamy P, Honey E, Ekure EN, Sokunbi OJ, Kalu N, Jones KL, Kaplan JD, Abdul-Rahman OA, Vincent LM, Love A, Belhassan K, Ouldim K, El Bouchikhi I, Shukla A, Girisha KM, Patil SJ, Sirisena ND, Dissanayake VHW, Paththinige CS, Mishra R, Klein-Zighelboim E, Gallardo Jugo BE, Chávez Pastor M, Abarca-Barriga HH, Skinner SA, Prijoles EJ, Badoe E, Gill AD, Shotelersuk V, Smpokou P, Kisling MS, Ferreira CR, Mutesa L, Megarbane A, Kline AD, Kimball A, Okello E, Lwabi P, Aliku T, Tenywa E, Boonchooduang N, Tanpaiboon P, Richieri-Costa A, Wonkam A, Chung BHY, Stevenson RE, Summar M, Mandal K, Phadke SR, Obregon MG, Linguraru MG, Muenke M.

Am J Med Genet A. 2017 Sep;173(9):i. doi: 10.1002/ajmg.a.38408.

PMID:
28816424
43.

New method to induce mild traumatic brain injury in rodents produces differential outcomes in female and male Sprague Dawley rats.

Wirth P, Yu W, Kimball AL, Liao J, Berkner P, Glenn MJ.

J Neurosci Methods. 2017 Oct 1;290:133-144. doi: 10.1016/j.jneumeth.2017.07.030. Epub 2017 Aug 2.

44.

Noonan syndrome in diverse populations.

Kruszka P, Porras AR, Addissie YA, Moresco A, Medrano S, Mok GTK, Leung GKC, Tekendo-Ngongang C, Uwineza A, Thong MK, Muthukumarasamy P, Honey E, Ekure EN, Sokunbi OJ, Kalu N, Jones KL, Kaplan JD, Abdul-Rahman OA, Vincent LM, Love A, Belhassan K, Ouldim K, El Bouchikhi I, Shukla A, Girisha KM, Patil SJ, Sirisena ND, Dissanayake VHW, Paththinige CS, Mishra R, Klein-Zighelboim E, Gallardo Jugo BE, Chávez Pastor M, Abarca-Barriga HH, Skinner SA, Prijoles EJ, Badoe E, Gill AD, Shotelersuk V, Smpokou P, Kisling MS, Ferreira CR, Mutesa L, Megarbane A, Kline AD, Kimball A, Okello E, Lwabi P, Aliku T, Tenywa E, Boonchooduang N, Tanpaiboon P, Richieri-Costa A, Wonkam A, Chung BHY, Stevenson RE, Summar M, Mandal K, Phadke SR, Obregon MG, Linguraru MG, Muenke M.

Am J Med Genet A. 2017 Sep;173(9):2323-2334. doi: 10.1002/ajmg.a.38362. Epub 2017 Jul 27.

45.

Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.

Feldman SR, Green L, Kimball AB, Siu K, Zhao Y, Herrera V, Nyirady J, Alexis AF.

J Dermatolog Treat. 2017 Dec;28(8):716-721. doi: 10.1080/09546634.2017.1329502. Epub 2017 Aug 3.

PMID:
28737440
46.

Psoriasis and latitude: Analytic approaches and future data needs.

Hartman RI, Kimball AB.

J Am Acad Dermatol. 2017 Aug;77(2):e59. doi: 10.1016/j.jaad.2017.04.1125. No abstract available.

PMID:
28711108
47.

The Histone Methyltransferase MLL1 Directs Macrophage-Mediated Inflammation in Wound Healing and Is Altered in a Murine Model of Obesity and Type 2 Diabetes.

Kimball AS, Joshi A, Carson WF 4th, Boniakowski AE, Schaller M, Allen R, Bermick J, Davis FM, Henke PK, Burant CF, Kunkel SL, Gallagher KA.

Diabetes. 2017 Sep;66(9):2459-2471. doi: 10.2337/db17-0194. Epub 2017 Jun 29.

48.

Macrophage-Mediated Inflammation in Normal and Diabetic Wound Healing.

Boniakowski AE, Kimball AS, Jacobs BN, Kunkel SL, Gallagher KA.

J Immunol. 2017 Jul 1;199(1):17-24. doi: 10.4049/jimmunol.1700223. Review.

49.

Observations from our evaluation of bodyweight changes after initiation of a biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Shear NH, Alhusayen R, Fernandez-Obregon A, Kimball AB, Menter A, Wu JJ, Goyal K, Patel H, Lin R, Armstrong AW.

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):e544-e547. doi: 10.1111/jdv.14414. Epub 2017 Jul 12. No abstract available.

PMID:
28622413
50.

Notch Regulates Macrophage-Mediated Inflammation in Diabetic Wound Healing.

Kimball AS, Joshi AD, Boniakowski AE, Schaller M, Chung J, Allen R, Bermick J, Carson WF 4th, Henke PK, Maillard I, Kunkel SL, Gallagher KA.

Front Immunol. 2017 Jun 1;8:635. doi: 10.3389/fimmu.2017.00635. eCollection 2017.

Supplemental Content

Loading ...
Support Center